Augmedix

Augmedix Equity

Delisted

The The Equity of Augmedix (AUGX) as of Oct 21, 2026 is 23.32 M USD. In the previous year, The Equity was 1.47 M USD — a change of 1,490.79% (higher).

Equity

23.32 MUSD

YoY

1,490.79%

Last updated:

In 2023, Augmedix's equity was 23.32 M USD, a 1,490.79% increase from the 1.47 M USD equity in the previous year.

The Augmedix Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
-65.14 M USD
Jan 1, 2020
3.12 M USD
Jan 1, 2021
23.68 M USD
Jan 1, 2022
1.47 M USD
Jan 1, 2023
23.32 M USD
The Augmedix Equity history
YEAREquityYoY
23.32 MUSD+1,490.79%
1.47 MUSD-93.81%
23.68 MUSD+658.13%
3.12 MUSD-104.80%
-65.14 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Augmedix Stock analysis

What does Augmedix do? Augmedix Inc. is a San Francisco-based company specializing in the development of technologies and software to assist medical professionals. It was founded in 2012 by Ian Shakil and Pelu Tran to change the way doctors capture and document patient data. The decision to start Augmedix was influenced by the personal experiences of the two founders. While working in the emergency room, Shakil noticed that he was constantly turning his back on his patients to create medical records, which took away from the actual treatment and interrupted visual contact with the patient. Based on his experiences, he saw an opportunity to help doctors focus more on their patients. Pelu Tran, the other founder, also worked in the healthcare industry and wanted to help doctors and nurses have more time for patient care. Augmedix's business model is based on the integration of speech technology and virtual reality. Augmedix has developed specialized software that directs doctors' attention away from data entry and towards treating their patients. Instead of focusing on writing notes, dictation, and clarifying paper notes, doctors can speak directly to a virtual assistant in real-time, who automates their records and embeds them into their medical records. Through this process automation, doctors can spend more time caring for their patients. Augmedix has now specialized in various areas within medical technology. For example, Augmedix offers speech technology platforms that surgical teams can use to access patient information and follow care protocols during surgery without leaving the operating table. There are also wireless mobile headsets that allow doctors to access patient information and create notes during patient treatment without interrupting contact between the doctor and patient. Augmedix also offers a telemedicine telepresence system that allows doctors and patients to communicate with each other via video calls. The system provides a convenient way for both patients and doctors to conduct and receive video consultations without the need for physical presence. Augmedix has become a major player in the digital healthcare industry, especially for doctors and hospitals. The company has already gained many customers in the US healthcare sector, including dozens of leading clinic chains. With its unique business model, Augmedix has taken a pioneering role in introducing new technologies in healthcare. In collaboration with the cloud computing platform Google Cloud, a dedicated medical security cloud platform and application for the healthcare industry are now being developed. Augmedix and Google Cloud now enable doctors to send medical data in real-time to their Augmedix virtual assistant and simultaneously update existing HIPAA-compliant patient records. Overall, Augmedix has become an important company for the introduction of new technologies in healthcare and can be proud to support doctors in their work and optimize healthcare for patients. Augmedix is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Augmedix's Equity

Augmedix's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Augmedix's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Augmedix's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Augmedix's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Augmedix’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Augmedix stock

The Equity of Augmedix is 23.32 M USD in 2023.

The Equity of Augmedix changed from 1.47 M USD to 23.32 M USD, representing a 1,490.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Augmedix since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Augmedix historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Augmedix

All Key Metrics — Augmedix